NCT00934219 - Triglyceride Lowering Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

December 31, 2012

Conditions

Hypertriglyceridemia

Interventions

DRUG

Omega-3-Acid Ethyl Esters

LOVAZA, 1 g caps; High Dose Arm for 4 months, while on a standard therapy for hypertriglyceridemia (fibrates, +/-metformin). Standard Dose Arm for 3 months, while on a standard, unchanged therapy for hypertriglyceridemia (fibrates +/- metformin).

Trial Locations (1)

45229

RECRUITING

Jewish Hospital Cholesterol Center, Cincinnati